XFOR

NASDAQStock

X4 Pharmaceuticals, Inc.

$3.73-0.15 (-3.87%)

52-Week Range

$1.42

$10.20

Key Stats

Market Cap

42.6M

P/E Ratio

—

Dividend Yield

—

Beta

0.46

Volume

178.4K

Avg Volume

663.3K

Performance

+15.13%

+3.19%

+29.77%

YTD

-0.26%

-61.97%

-85.72%

-98.62%

Price Chart

ETF Exposure

XFOR is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.00%	894,054	$3.3M	$84.10B	0.05%
URTY	ProShares - UltraPro Russell2000	0.00%	1	$3	$284.9M	1.08%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	115	$579	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	4,127	$21K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	19	$100	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	2,349,867	$8.7M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	12,359	$62K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,065	$5K	$1.29B	0.17%

About XFOR ETF Exposure

X4 Pharmaceuticals, Inc. (XFOR) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 42.6M, XFOR is a widely held institutional stock. The stock currently trades at $3.73. Investors can gain exposure to XFOR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold XFOR, sorted by portfolio weight.